Transfuze a hematologie dnes

Obinutuzumab in the treatment of a patient with Waldenström macroglobulinemia and rituximab intolerance – a case report

Transfuze a hematologie dnes ◽

10.48095/cctahd2021160 ◽

2021 ◽

Vol 27 (2) ◽

pp. 160-165

Author(s):

Zdeněk Adam ◽

Marta Krejčí ◽

Luděk Pour ◽

Martin Štork ◽

Viera Sandecká ◽

...

Keyword(s):

Case Report ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

Changes in the immune system of untreated patients with chronic lymphocytic leukaemia – part 1: adaptive immunity

Transfuze a hematologie dnes ◽

10.48095/cctahd2021128 ◽

2021 ◽

Vol 27 (2) ◽

pp. 128-136

Author(s):

Pavel Vodárek ◽

Lukáš Šimkovič ◽

David Belada ◽

Martin Šimkovič ◽

Dominika Écsiová ◽

...

Keyword(s):

Immune System ◽

Chronic Lymphocytic Leukaemia ◽

Adaptive Immunity ◽

Lymphocytic Leukaemia

Download Full-text

A peripherally inserted central catheter is a safe means of ensuring long-term central venous access in patients with acute leukaemia – a single centre experience

Transfuze a hematologie dnes ◽

10.48095/cctahd2021147 ◽

2021 ◽

Vol 27 (2) ◽

pp. 147-153

Author(s):

Tomáš Szotkowski ◽

Martin Čerňan ◽

Lucia Vráblová ◽

Peter Rohoň ◽

Veronika Hájková ◽

...

Keyword(s):

Acute Leukaemia ◽

Central Venous Access ◽

Venous Access ◽

Peripherally Inserted Central Catheter ◽

Central Catheter ◽

Single Centre ◽

Central Venous ◽

Single Centre Experience

Download Full-text

Transfusion related acute lung injury (TRALI) prevention – selection of donors for producing plasma designated for clinical use

Transfuze a hematologie dnes ◽

10.48095/cctahd2021154 ◽

2021 ◽

Vol 27 (2) ◽

pp. 154-158

Author(s):

Vít Řeháček

Keyword(s):

Acute Lung Injury ◽

Lung Injury ◽

Clinical Use ◽

Selection Of

Download Full-text

Mucormycosis – review of literature and case report

Transfuze a hematologie dnes ◽

10.48095/cctahd2021137 ◽

2021 ◽

Vol 27 (2) ◽

pp. 137-145

Author(s):

Martin Čerňan ◽

Tomáš Szotkowski ◽

Renata Machová ◽

Miroslava Palová ◽

Petr Hamal ◽

...

Keyword(s):

Case Report ◽

Review Of Literature

Download Full-text

Pitfalls of treating chronic myeloid leukaemia with dasatinib – pulmonary arterial hypertension as a rare complication

Transfuze a hematologie dnes ◽

10.48095/cctahd2021166 ◽

2021 ◽

Vol 27 (2) ◽

pp. 166-171

Author(s):

Petra Čičátková ◽

Anežka Kvetková ◽

Tomáš Horňák ◽

Lukáš Semerád ◽

Daniela Žáčková

Keyword(s):

Pulmonary Arterial Hypertension ◽

Chronic Myeloid Leukaemia ◽

Arterial Hypertension ◽

Myeloid Leukaemia ◽

Rare Complication ◽

Pulmonary Arterial

Download Full-text

Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with congenital haemophilia and FVIII/ FIX inhibitors

Transfuze a hematologie dnes ◽

10.48095/cctahd2021173 ◽

2021 ◽

Vol 27 (2) ◽

pp. 173-184

Author(s):

Ester Zápotocká ◽

Jan Blatný ◽

Petr Smejkal

Keyword(s):

Diagnosis And Treatment

Download Full-text

Muscle pain as a rare autoimmune symptom of monoclonal IgM gammopathy – case report and overview of autoimmune manifestations associated with monoclonal immunoglobulins

Transfuze a hematologie dnes ◽

10.48095/cctahd202157 ◽

2021 ◽

Vol 27 (1) ◽

pp. 57-61

Author(s):

Zdeněk Král ◽

Marta Krejčí ◽

Luděk Pour ◽

Zdeněk Adam

Keyword(s):

Case Report ◽

Muscle Pain ◽

Monoclonal Immunoglobulins

Download Full-text

"Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia"

Transfuze a hematologie dnes ◽

10.48095/cctahd202163 ◽

2021 ◽

Vol 27 (1) ◽

pp. 63-71

Author(s):

Angelika Bátorová ◽

Tatiana Prigancová ◽

Denisa Jankovičová ◽

Anna Kyselová

Keyword(s):

Factor Viii ◽

Bispecific Antibody

Download Full-text

What is the optimal dose of tyrosine kinase inhibitors in chronic myeloid leukaemia?

Transfuze a hematologie dnes ◽

10.48095/cctahd202128 ◽

2021 ◽

Vol 27 (1) ◽

pp. 28-41

Author(s):

Daniela Žáčková ◽

Petra Čičátková ◽

Anežka Kvetková ◽

Tomáš Horňák ◽

Lukáš Semerád ◽

...

Keyword(s):

Chronic Myeloid Leukaemia ◽

Tyrosine Kinase ◽

Myeloid Leukaemia ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Optimal Dose

Download Full-text

Transfuze a hematologie dnes
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Care Comm

Obinutuzumab in the treatment of a patient with Waldenström macroglobulinemia and rituximab intolerance – a case report

Changes in the immune system of untreated patients with chronic lymphocytic leukaemia – part 1: adaptive immunity

A peripherally inserted central catheter is a safe means of ensuring long-term central venous access in patients with acute leukaemia – a single centre experience

Transfusion related acute lung injury (TRALI) prevention – selection of donors for producing plasma designated for clinical use

Mucormycosis – review of literature and case report

Pitfalls of treating chronic myeloid leukaemia with dasatinib – pulmonary arterial hypertension as a rare complication

Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with congenital haemophilia and FVIII/ FIX inhibitors

Muscle pain as a rare autoimmune symptom of monoclonal IgM gammopathy – case report and overview of autoimmune manifestations associated with monoclonal immunoglobulins

"Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia"

What is the optimal dose of tyrosine kinase inhibitors in chronic myeloid leukaemia?

Export Citation Format

Transfuze a hematologie dnesLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Care Comm

Obinutuzumab in the treatment of a patient with Waldenström macroglobulinemia and rituximab intolerance – a case report

Changes in the immune system of untreated patients with chronic lymphocytic leukaemia – part 1: adaptive immunity

A peripherally inserted central catheter is a safe means of ensuring long-term central venous access in patients with acute leukaemia – a single centre experience

Transfusion related acute lung injury (TRALI) prevention – selection of donors for producing plasma designated for clinical use

Mucormycosis – review of literature and case report

Pitfalls of treating chronic myeloid leukaemia with dasatinib – pulmonary arterial hypertension as a rare complication

Consensual guidelines of the Czech National Haemophilia Programme (CNHP) for the diagnosis and treatment of patients with congenital haemophilia and FVIII/ FIX inhibitors

Muscle pain as a rare autoimmune symptom of monoclonal IgM gammopathy – case report and overview of autoimmune manifestations associated with monoclonal immunoglobulins

"Factor VIII inhibitors – Results of immunotolerance induction at the National Haemophilia Centre; new options and first experience with treatment using a bispecific antibody (emicizumab) in patients with inhibitors in Slovakia"

What is the optimal dose of tyrosine kinase inhibitors in chronic myeloid leukaemia?

Transfuze a hematologie dnes
Latest Publications